<DOC>
	<DOCNO>NCT01574872</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Aerosal® compare placebo prognosis inverse psoriasis sebopsoriasis present least one year</brief_summary>
	<brief_title>Efficacy Aerosal® Treatment Inverse Psoriasis Sebopsoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<criteria>Inverse Psoriasis Sebopsoriasis last one year At least 1 % total body surface area involvement Suspension 3 month start study systemic drug psoriasis , immunosuppressive treatment ( cyclosporin , systemic steroid ) , psoralen plus ultraviolet A irradiation ( PUVA ) ultraviolet B phototherapy ( UVB ) Patients acute bronchopulmonary disease , tuberculosis , severe hypertension , hyperthyroidism , cancer ( chemotherapy ) , intoxication , heart failure Iodine allergy Women pregnant planning become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>salt</keyword>
	<keyword>sodium chloride</keyword>
</DOC>